{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T05:27:11Z","timestamp":1784352431665,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiol med"],"DOI":"10.1007\/s11547-023-01618-5","type":"journal-article","created":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T11:04:46Z","timestamp":1679569486000},"page":"501-508","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Extreme hypofractionated stereotactic radiotherapy for elderly prostate cancer patients: side effects preliminary analysis of a phase II trial"],"prefix":"10.1007","volume":"128","author":[{"given":"Fabiana","family":"Gregucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Carbonara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4502-9635","authenticated-orcid":false,"given":"Alessia","family":"Surgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Paola","family":"Ciliberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Curci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annarita","family":"Ciocia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Bran\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe Mario","family":"Ludovico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Scarcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Portoghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morena","family":"Caliandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Ludovico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Paulicelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiorella Cristina","family":"Di Guglielmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Bonaparte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Fiorentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,23]]},"reference":[{"issue":"3","key":"1618_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249","journal-title":"CA Cancer J Clin"},{"key":"1618_CR2","doi-asserted-by":"crossref","unstructured":"Carretero Gonz\u00e1lez A, Mart\u00edn MC, Luyo M, et al (2019) Challenges of treatment selection in the older prostate patient. J Geriatr Oncol. pii:S1879 4068(18)30380\u20131","DOI":"10.1016\/j.jgo.2019.01.009"},{"key":"1618_CR3","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1056\/NEJMoa1606220","volume":"375","author":"FC Hamdy","year":"2016","unstructured":"Hamdy FC, Donovan JL, Lane JA et al (2016) 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med 375:1415\u20131424","journal-title":"N Engl J Med"},{"issue":"5","key":"1618_CR4","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.ijrobp.2016.05.004","volume":"96","author":"P Dell'Oglio","year":"2016","unstructured":"Dell\u2019Oglio P, Boehm K, Trudeau V et al (2016) Survival after conservative management versus external beam radiation therapy in elderly patients with localized prostate cancer. Int J Radiat Oncol Biol Phys 96(5):1037\u20131045","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1618_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.canep.2017.11.002","volume":"51","author":"C Dunn","year":"2017","unstructured":"Dunn C, Wilson A, Sitas F (2017) Older cancer patients in cancer clinical trials are underrepresented. Systematic literature review of almost 5000 meta- and pooled analyses of phase III randomized trials of survival from breast, prostate and lung cancer. Cancer Epidemiol 51:113\u2013117","journal-title":"Cancer Epidemiol"},{"issue":"4\u20135","key":"1618_CR6","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.euf.2017.10.010","volume":"3","author":"C Hernandez Torres","year":"2017","unstructured":"Hernandez Torres C, Hsu T (2017) Comprehensive geriatric assessment in the older adult with cancer: a review. Eur Urol Focus 3(4\u20135):330\u2013339","journal-title":"Eur Urol Focus"},{"issue":"24","key":"1618_CR7","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1200\/JCO.2014.55.1531","volume":"32","author":"C Fung","year":"2014","unstructured":"Fung C, Dale W, Mohile SG (2014) Prostate cancer in the elderly patient. J Clin Oncol 32(24):2523\u20132530","journal-title":"J Clin Oncol"},{"key":"1618_CR8","doi-asserted-by":"publisher","first-page":"830","DOI":"10.3389\/fonc.2020.00830","volume":"10","author":"VR Adorno Febles","year":"2020","unstructured":"Adorno Febles VR, Blacksburg S, Haas JA, Wise DR (2020) Translating the immunobiology of sbrt to novel therapeutic combinations for advanced prostate cancer. Front Oncol 10:830","journal-title":"Front Oncol"},{"issue":"4","key":"1618_CR9","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s00432-020-03152-7","volume":"146","author":"B Meduri","year":"2020","unstructured":"Meduri B, Gregucci F, D\u2019Angelo E et al (2020) Volume de-escalation in radiation therapy: state of the art and new perspectives. J Cancer Res Clin Oncol 146(4):909\u2013924","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"1618_CR10","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.adro.2017.07.010","volume":"2","author":"KR Voong","year":"2017","unstructured":"Voong KR, Lal LS, Kuban DA et al (2017) Long-term economic value of hypofractionated prostate radiation: Secondary analysis of a randomized trial. Adv Radiat Oncol 2(3):249\u2013258","journal-title":"Adv Radiat Oncol"},{"issue":"10196","key":"1618_CR11","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0140-6736(19)31131-6","volume":"394","author":"A Widmark","year":"2019","unstructured":"Widmark A, Gunnlaugsson A, Beckman L et al (2019) Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial. Lancet 394(10196):385\u2013395","journal-title":"Lancet"},{"key":"1618_CR12","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/S1470-2045(16)30102-4","volume":"17","author":"D Dearnaley","year":"2016","unstructured":"Dearnaley D, Syndikus I, Mossop H et al (2016) Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-Year outcomes of the randomised, non- inferiority, phase 3 CHHiP trial. Lancet Oncol 17:1047\u20131060","journal-title":"Lancet Oncol"},{"issue":"5","key":"1618_CR13","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.ijrobp.2018.01.016","volume":"100","author":"JM Wilson","year":"2018","unstructured":"Wilson JM, Dearnaley DP, Syndikus I et al (2018) The efficacy and safety of conventional and hypofractionated high-dose radiation therapy for prostate cancer in an elderly population: a subgroup analysis of the CHHiP trial. Int J Radiat Oncol Biol Phys 100(5):1179\u20131189","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1618_CR14","doi-asserted-by":"crossref","unstructured":"Brand DH, Tree AC, Ostler P, et al (2019) Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial Lancet Oncol 20(11):1531\u20131543","DOI":"10.1016\/S1470-2045(19)30569-8"},{"issue":"2","key":"1618_CR15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00066-018-1338-7","volume":"195","author":"F Alongi","year":"2019","unstructured":"Alongi F, Mazzola R, Fiorentino A et al (2019) Phase\u00a0II study of accelerated Linac-based SBRT in five consecutive fractions for localized prostate cancer. Strahlenther Onkol 195(2):113\u2013120","journal-title":"Strahlenther Onkol"},{"issue":"4","key":"1618_CR16","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.ijrobp.2019.07.027","volume":"105","author":"G Marvaso","year":"2019","unstructured":"Marvaso G, Ciardo D, Gandini S et al (2019) Comparison of outcomes and toxicity between extreme and moderate radiation therapy hypofractionation in localized prostate cancer: a propensity score analysis. Int J Radiat Oncol Biol Phys 105(4):735\u2013744","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1618_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13014-022-01998-4","volume":"17","author":"TG Kim","year":"2022","unstructured":"Kim TG, Park B, Song YG et al (2022) Patient-related risk factors for late rectal bleeding after hypofractionated radiotherapy for localized prostate cancer: a single-center retrospective study. Radiat Oncol 17(1):30","journal-title":"Radiat Oncol"},{"key":"1618_CR18","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.ijrobp.2012.10.042","volume":"85","author":"DA Hamstra","year":"2013","unstructured":"Hamstra DA, Stenmark MH, Ritter T et al (2013) Age and comorbid illness are associated with late rectal toxicity following dose-escalated radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys 85:1246\u20131253","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6\u20137","key":"1618_CR19","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.canrad.2018.07.124","volume":"22","author":"P Sargos","year":"2018","unstructured":"Sargos P, Cr\u00e9hange G, Hennequin C et al (2018) Hypofractionnated radiotherapy for elderly patients with prostate cancer. Cancer Radiother 22(6\u20137):631\u2013634","journal-title":"Cancer Radiother"},{"key":"1618_CR20","unstructured":"R Core Team (2018) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. https:\/\/www.R-project.org\/"},{"issue":"3","key":"1618_CR21","first-page":"274","volume":"25","author":"C Chiumento","year":"2013","unstructured":"Chiumento C, Fiorentino A, Cozzolino M et al (2013) Impact of comorbidity in elderly prostate cancer patients treated with brachytherapy. Chin J Cancer Res 25(3):274\u2013280","journal-title":"Chin J Cancer Res"},{"issue":"1","key":"1618_CR22","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/bjc.2013.268","volume":"109","author":"CM de Camargo","year":"2013","unstructured":"de Camargo CM, Comber H, Sharp L (2013) Age remains the major predictor of curative treatment non-receipt for localised prostate cancer: a population-based study. Br J Cancer 109(1):272\u2013279","journal-title":"Br J Cancer"},{"issue":"7","key":"1618_CR23","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.3390\/jcm9072296","volume":"9","author":"H Yamazaki","year":"2020","unstructured":"Yamazaki H, Masui K, Suzuki G et al (2020) Potential risk of other-cause mortality due to long-term androgen deprivation therapy in elderly patients with clinically localized prostate cancer treated with radiotherapy-a confirmation study. J Clin Med 9(7):2296","journal-title":"J Clin Med"},{"issue":"5","key":"1618_CR24","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1586\/14737140.2014.883282","volume":"14","author":"B De Bari","year":"2014","unstructured":"De Bari B, Fiorentino A, Arcangeli S et al (2014) From radiobiology to technology: what is changing in radiotherapy for prostate cancer. Expert Rev Anticancer Ther 14(5):553\u2013564","journal-title":"Expert Rev Anticancer Ther"},{"issue":"16","key":"1618_CR25","first-page":"3563","volume":"21","author":"R Di Franco","year":"2017","unstructured":"Di Franco R, Borzillo V, Ravo V et al (2017) Rectal\/urinary toxicity after hypofractionated vs. conventional radiotherapy in high risk prostate cancer: systematic review and meta analysis. Eur Rev Med Pharmacol Sci 21(16):3563\u20133575","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"4","key":"1618_CR26","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s40520-019-01243-1","volume":"32","author":"F Cuccia","year":"2020","unstructured":"Cuccia F, Fiorentino A, Corrao S et al (2020) Moderate hypofractionated helical tomotherapy for prostate cancer in a cohort of older patients: a mono-institutional report of toxicity and clinical outcomes. Aging Clin Exp Res 32(4):747\u2013753","journal-title":"Aging Clin Exp Res"},{"issue":"4","key":"1618_CR27","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1177\/1533034615593189","volume":"15","author":"HX Liu","year":"2016","unstructured":"Liu HX, Du L, Yu W et al (2016) Hypofractionated helical tomotherapy for older aged patients with prostate cancer: preliminary results of a Phase I\u2013II trial. Technol Cancer Res Treat 15(4):546\u2013554","journal-title":"Technol Cancer Res Treat"},{"key":"1618_CR28","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1002\/(SICI)1097-0142(19980515)82:10+<2057::AID-CNCR14>3.0.CO;2-A","volume":"82","author":"WT McGivney","year":"1998","unstructured":"McGivney WT (1998) The national comprehensive cancer network. Cancer 82:2057\u20132060","journal-title":"Cancer"},{"key":"1618_CR29","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1471-2407-12-54","volume":"12","author":"AD Sasse","year":"2012","unstructured":"Sasse AD, Sasse E, Carvalho AM et al (2012) Androgenic suppression combined with radiotherapy for the treatment of prostate adenocarcinoma: a systematic review. BMC Cancer 12:54","journal-title":"BMC Cancer"},{"key":"1618_CR30","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S1470-2045(15)70045-8","volume":"16","author":"A Zapatero","year":"2015","unstructured":"Zapatero A, Guerrero A, Maldonado X et al (2015) High-dose radiotherapy with short-term or long-term androgen deprivation in localized prostate cancer (DART01\/05 GICOR): a randomized, controlled, phase 3 trial. Lancet Oncol 16:320\u2013327","journal-title":"Lancet Oncol"},{"issue":"4","key":"1618_CR31","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.ijrobp.2019.03.051","volume":"104","author":"WC Jackson","year":"2019","unstructured":"Jackson WC, Silva J, Hartman HE et al (2019) Stereotactic body radiation therapy for localized prostate cancer: a systematic review and meta-analysis of over 6000 patients treated on prospective studies. Int J Radiat Oncol Biol Phys 104(4):778\u2013789","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1618_CR32","doi-asserted-by":"publisher","unstructured":"Bon\u00fa ML, Magli A, Tomasini D, et al (2022) Stereotactic prostate radiotherapy with or without androgen deprivation therapy, study protocol for a phase III, multi-institutional randomized-controlled trial. BJR; published online:12 Dec 2022. https:\/\/doi.org\/10.1259\/bjro.20220032","DOI":"10.1259\/bjro.20220032"},{"issue":"3","key":"1618_CR33","doi-asserted-by":"publisher","first-page":"153","DOI":"10.5694\/mja14.00441","volume":"202","author":"RC Khor","year":"2015","unstructured":"Khor RC, Bressel M, Tedesco J et al (2015) Tolerability and outcomes of curative radiotherapy in patients aged 85 or more years. Med J Aust 202(3):153\u2013155","journal-title":"Med J Aust"},{"key":"1618_CR34","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/j.ejca.2014.02.012","volume":"50","author":"C Chargari","year":"2014","unstructured":"Chargari C, Moriceau G, Auberdiac P et al (2014) Feasibility of radiation therapy in patients 90 years of age and older: a French multicentre analysis. Eur J Cancer 50:1490\u20131497","journal-title":"Eur J Cancer"},{"key":"1618_CR35","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ijrobp.2009.01.081","volume":"76","author":"T Pickles","year":"2010","unstructured":"Pickles T, Keyes M, Morris WJ (2010) Brachytherapy or conformal external radiotherapy for prostate cancer: a single-institution matched-pair analysis. Int J Radiat Oncol Biol Phys 76:43\u201349","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1618_CR36","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0360-3016(03)00784-3","volume":"58","author":"PA Kupelian","year":"2004","unstructured":"Kupelian PA, Potters L, Khuntia D et al (2004) Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds\/external beam radiotherapy for stage T1\u2013T2 prostate cancer. Int J Radiat Oncol Biol Phys 58:25\u201333","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1618_CR37","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.3389\/fonc.2019.01528","volume":"9","author":"N Aghdam","year":"2020","unstructured":"Aghdam N, Pepin A, Carrasquilla M et al (2020) Self-reported burden in elderly patients with localized prostate cancer treated with stereotactic body radiation therapy (SBRT). Front Oncol 9:1528","journal-title":"Front Oncol"}],"container-title":["La radiologia medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-023-01618-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11547-023-01618-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-023-01618-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T13:53:20Z","timestamp":1681998800000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11547-023-01618-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,23]]},"references-count":37,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["1618"],"URL":"https:\/\/doi.org\/10.1007\/s11547-023-01618-5","relation":{},"ISSN":["1826-6983"],"issn-type":[{"value":"1826-6983","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,23]]},"assertion":[{"value":"2 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}